single-domain antibody

single-domain antibody

A synthetic antibody that contains a single immunoglobulin chain with the variable regions of a heavy (VH) or light (VL) binding units of an immunoglobulin chain.
References in periodicals archive ?
Offering the first demonstration of molecular engineering to increase the thermal stability of shark-derived antibodies, researchers published their success in a PLOS ONE journal submission, "Importance of Hypervariable Region 2 for Stability and Affinity of a Shark Single-Domain Antibody Specific for Ebola Virus Nucleoprotein.
Ablynx's Nanobodies are a new class of therapeutic proteins based on single-domain antibody fragments, for various human diseases, including inflammation, haematology, oncology and pulmonary disease.
Founded in 2001 in, Ablynx is a biopharmaceutical company focused on the discovery and development of Nanobodies, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious and life-threatening human diseases.
Ablynx is a pioneer in the discovery and development of Nanobodies, a novel class of therapeutic proteins based on single-domain antibody fragments and designed for a range of serious and life-threatening human diseases.
Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies[R], a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious and life-threatening human diseases.
Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies([R]), a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious and life-threatening human diseases.